(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-fluorophenyl)propanoic acid, 98%, 1g

6-BROMO-2-FLUORO-PYRIDINE-3-CARBALDEHYDE, 90.0%, 250mg

4-Bromo-2,6-dimethoxybenzoic acid, 98%, 100mg

2-(5-Bromopyridin-2-yl)acetonitrile, 95.0%, 1g

CMEX-Explorer 1 1,3 MP et résolution 1520 x 856

[1-(2,4-Dichloro-benzenesulfonyl)-piperidin-2-yl]-methanol, 95.0%, 100mg

N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-N'-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]urea, 98%, 5mg

[3,3'-Bipyridine]-6,6'-dicarboxaldehyde, 97%, 100mg

Flacons à vis conique stérile, gradués, 2 ml, 500 Pièce(s)

5-chloro-1-methyl-1H-1,2,4-triazole, 95.0%, 250mg

(2-Hydroxy-4-(octyloxy)phenyl)(phenyl)methanone, 95.0%, 100g

(R)-1-(2-Chloropyridin-3-yl)ethanol, 98%, 250mg

2-Methylbenzothiazole, 95.0%, 500g